Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.75B |
| 2 |
MSLC
Morgan Stanley Pathway Large Cap Equity ETF
MSLC
|
+$2.07B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$1.75B |
| 4 |
Apple
AAPL
|
+$1.6B |
| 5 |
Tesla
TSLA
|
+$1.58B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.7B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.35B |
| 3 |
Strategy Inc
MSTR
|
+$1.3B |
| 4 |
Shopify
SHOP
|
+$1.14B |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.03B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.55% |
| 2 | Financials | 11.55% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Healthcare | 8.08% |
| 5 | Communication Services | 6.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5226
Rekor Systems
REKR
$88.2M
| $558K | ﹤0.01% |
357,612
-297,716
| -45% | -$309K |
|
|
MBCN
5227
DELISTED
Middlefield Banc Corp
MBCN
| $555K | ﹤0.01% |
19,786
-3,271
| -14% | -$97.2K |
|
5228
Bel Fuse Inc Class A
BELFA
$3.4B
| $553K | ﹤0.01% |
6,133
-520
| -8% | -$51.4K |
|
5229
First Community Corp
FCCO
$324M
| $552K | ﹤0.01% |
22,997
+7,201
| +46% | +$172K |
|
5230
Invesco DB Precious Metals Fund
DBP
$250M
| $550K | ﹤0.01% |
9,057
-1,597
| -15% | -$103K |
|
5231
Compass Therapeutics
CMPX
$340M
| $549K | ﹤0.01% |
378,552
+665
| +0.2% | +$1.1K |
|
5232
RLJ Lodging Trust $1.95 Series A Preferred Stock
RLJ.PRA
$323M
| $548K | ﹤0.01% |
22,318
-70
| -0.3% | -$1.78K |
|
5233
Princeton Bancorp
BPRN
$287M
| $547K | ﹤0.01% |
15,896
-926
| -6% | -$34K |
|
5234
Sonida Senior Living
SNDA
$1.89B
| $542K | ﹤0.01% |
23,486
+4,267
| +22% | +$105K |
|
|
FFNW
5235
DELISTED
First Financial Northwest, Inc
FFNW
| $542K | ﹤0.01% |
24,979
+2,511
| +11% | +$56.1K |
|
|
IPX
5236
IperionX
IPX
$861M
| $542K | ﹤0.01% |
15,750
-16,850
| -52% | -$439K |
|
|
ASRT
5237
DELISTED
Assertio
ASRT
| $539K | ﹤0.01% |
41,238
-5,845
| -12% | -$87.1K |
|
5238
Virtus Biotech ETF
BBP
$96.9M
| $537K | ﹤0.01% |
8,954
+200
| +2% | +$12.6K |
|
|
ADVM
5239
DELISTED
Adverum Biotechnologies
ADVM
| $536K | ﹤0.01% |
114,788
+25,605
| +29% | +$172K |
|
5240
Benitec Biopharma
BNTC
$436M
| $535K | ﹤0.01% |
42,367
+41,043
| +3,100% | +$443K |
|
|
NTZ
5241
Natuzzi
NTZ
$14.8M
| $533K | ﹤0.01% |
111,143
-4,700
| -4% | -$20.5K |
|
5242
Clarus
CLAR
$129M
| $533K | ﹤0.01% |
118,127
+8,932
| +8% | +$40.1K |
|
5243
SkinHealth Systems
SKIN
$91.4M
| $530K | ﹤0.01% |
333,453
+53,773
| +19% | +$84.5K |
|
5244
Nuveen Short-Term REIT ETF
NURE
$36M
| $529K | ﹤0.01% |
16,648
+295
| +2% | +$9.76K |
|
|
FSUN
5245
FirstSun Capital Bancorp
FSUN
$1.97B
| $528K | ﹤0.01% |
13,184
+12,138
| +1,160% | +$476K |
|
5246
Protara Therapeutics
TARA
$225M
| $526K | ﹤0.01% |
+99,527
| New | +$322K |
|
5247
Aemetis
AMTX
$109M
| $524K | ﹤0.01% |
194,845
+8,724
| +5% | +$27.4K |
|
5248
Evotec
EVO
$704M
| $524K | ﹤0.01% |
125,921
+3,467
| +3% | +$14.6K |
|
5249
Nuveen Minnesota Quality Municipal Income Fund
NMS
$73.5M
| $521K | ﹤0.01% |
42,203
-999
| -2% | -$13K |
|
|
DFSV
5250
Dimensional US Small Cap Value ETF
DFSV
$8.34B
| $518K | ﹤0.01% |
16,827
+1,013
| +6% | +$32.1K |
|
Similar funds
Morgan Stanley's Q4 2024 Portfolio in Review
As of Q4 2024, Morgan Stanley held 8,265 positions worth $1.43T, up 3.5% from $1.38T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Morgan Stanley's Q4 2024 filing shows 346 new, 3,539 increased, 3,177 reduced and 287 closed positions. Its largest new stake was Morgan Stanley Pathway Large Cap Equity ETF: 42,204,466 shares worth $2.03B. The largest sale was iShares 20+ Year Treasury Bond ETF, an estimated $1.7B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q4 2024 buy was Morgan Stanley Pathway Large Cap Equity ETF: 42,204,466 shares worth $2.03B.
- Morgan Stanley added most to NVIDIA in Q4 2024, an estimated $2.75B increase.
- Morgan Stanley's biggest Q4 2024 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $1.7B.
- Morgan Stanley fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $259M.
- Morgan Stanley's ten largest holdings make up 22% of its $1.43T portfolio in Q4 2024.
- Morgan Stanley opened 346 new positions and closed 287 in Q4 2024.
- Morgan Stanley's portfolio value rose 3.5% quarter-over-quarter to $1.43T.
Based on Morgan Stanley's 13F filing for Q4 2024, filed 14 Feb 2025.